Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1983 Feb 26;286(6366):695–697. doi: 10.1136/bmj.286.6366.695

New drugs. H2 receptor antagonists--cimetidine and ranitidine.

J Feely, K G Wormsley
PMCID: PMC1547117  PMID: 6130817

Full text

PDF
696

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Black J. W., Duncan W. A., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H 2 -receptors. Nature. 1972 Apr 21;236(5347):385–390. doi: 10.1038/236385a0. [DOI] [PubMed] [Google Scholar]
  2. Brogden R. N., Carmine A. A., Heel R. C., Speight T. M., Avery G. S. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs. 1982 Oct;24(4):267–303. doi: 10.2165/00003495-198224040-00002. [DOI] [PubMed] [Google Scholar]
  3. Freston J. W. Cimetidine. I. Developments, pharmacology, and efficacy. Ann Intern Med. 1982 Oct;97(4):573–580. doi: 10.7326/0003-4819-97-4-573. [DOI] [PubMed] [Google Scholar]
  4. Henry D. A., Langman M. J. Adverse effects of anti-ulcer drugs. Drugs. 1981 Jun;21(6):444–459. doi: 10.2165/00003495-198121060-00004. [DOI] [PubMed] [Google Scholar]
  5. Venables C. W., Wheldon E. J., Cranage J. D. Adverse effects of gastric surgery for peptic ulceration. J R Coll Physicians Lond. 1980 Jul;14(3):173–177. [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES